Ann H. Partridge

Dr. Partridge is a practicing medical oncologist and clinical researcher. She is vice chair of the Department of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as director of the Adult Survivorship Program and co-founder and director of the Program for Young Women with Breast Cancer. She is a professor at Harvard Medical School and holds the Eric P. Winer Chair in Breast Cancer Research at Dana-Farber. Dr. Partridge has sought to reduce morbidity and mortality from cancer through innovative research, guideline development, dedicated educational efforts, mentoring junior colleagues, and direct patient care. She has led studies focused on cancer disparities, risk perceptions, decision-making, quality of life, adherence with anti-cancer therapy, and cancer survivorship. She is particularly committed to research to reduce disparities in outcomes among young women with breast cancer. Dr. Partridge has served on numerous ASCO committees and initiatives including as Chair of the Clinical Practice Guidelines Committee as well as Chair of the Scientific Program Committee for the 2018 Annual Meeting. She chaired the Center for Disease Control’s Advisory Committee on Breast Cancer in Young Women from 2010-2017 and is leading national clinical research endeavors as co-Chair of the Alliance for Clinical Trials in Oncology Breast Committee and a member of the NCI Breast Cancer Steering Committee. Dr. Partridge is a recipient of a Champions of Change award from the U.S. White House, the AACR Outstanding Investigator Award for Breast Cancer, and ASCO’s Ellen L. Stovall Award for Advancement of Cancer Survivorship Care from Conquer Cancer.